PhaseBio Pharmaceuticals Inc

CIK 1169245 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for PhaseBio Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Sep 30, 202415-12G0001193125-24-229002
Sep 30, 2024S-8 POS0001193125-24-228992
Sep 30, 2024S-8 POS0001193125-24-229001
Sep 30, 2024S-8 POS0001193125-24-228996
Sep 30, 2024S-8 POS0001193125-24-228998
Sep 30, 2024S-8 POS0001193125-24-228985
Aug 15, 2024NT 10-Q0001193125-24-201302
Aug 15, 20248-K0001193125-24-201295
Jul 12, 20248-K0001193125-24-178615
May 16, 20248-K0001193125-24-140615
May 16, 2024NT 10-Q0001193125-24-140626
Apr 2, 2024NT 10-K0001193125-24-084778
Mar 12, 20248-K0001193125-24-065935
Nov 29, 20238-K0001169245-23-000056
Nov 15, 2023NT 10-Q0001169245-23-000054
Oct 3, 20238-K0001169245-23-000052
Sep 27, 20238-K0001169245-23-000050
Aug 25, 2023NT 10-Q0001169245-23-000045
Aug 25, 20238-K0001169245-23-000047
Jun 30, 20238-K0001169245-23-000039
May 30, 20238-K0001169245-23-000035
May 19, 202340001169245-23-000028
May 19, 202340001169245-23-000027
May 19, 202340001169245-23-000030
May 19, 202340001169245-23-000031